Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on July 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Supply and Delivery of Agilent Cytation 9 Instrument and Accessories

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract entails the supply, delivery, and shipment of an Agilent Cytation 9 multimode cell imaging system complete with designated filter cubes, objectives, and software necessary for full operational capability. This equipment is intended to support advanced cellular imaging and analysis functions, with all components specified to ensure compatibility and peak performance within the intended research or testing environment. The instrument must be delivered in working condition, properly configured, and accompanied by all required documentation to support installation and routine use. The solicitation is issued under the Department of Health and Human Services through the FDA Office of Acquisition and Grant Services, classified under NAICS code 334516 for medical and dental equipment manufacturing. The opportunity is structured as a subcontract with a response deadline of July 16, 2026, at 2:00 PM Eastern Time, and was posted on July 8, 2026. No set-aside designation applies, and the place of performance and point of contact details are not provided, indicating that the delivery location and coordination will be determined during award and fulfillment. All proposals must fully address the technical specifications and delivery requirements outlined in the solicitation to be considered.

General Info

Agilent Cytation 9 imaging system delivery with accessories for FDA use by July 16, 2026.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

This scope was carved out of 75F40126Q135511.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Agilent Cytation 9 Cell Imaging Multimode Reader, or equivalent instrument

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply, delivery, and shipment of the Agilent Cytation 9 multimode cell imaging system with specified filter cubes, objectives, and software for full operation.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS